Hearty congratulations to John Cieslak and Josh Schoenfeld for being selected to participate in this year’s SFRBM meeting in Seattle. Both John and Josh were selected to present oral presentations. The title of John’s presentation is “The Addition of Manganoporphyrins and Ascorbate to Standard of Care Chemotherapy Enhances Tumor-Specific Cytotoxicity in Pancreatic Cancer.” The title of and Josh’s presentation is “Intracellular redox active metal ions mediate the differential susceptibility of lung and brain cancer cells to pharmacological ascorbate.”
John Cieslak is also the recipient of a travel award to attend this year’s conference. Congratulations to both!